WashU announces new academic-industry collaboration with Bristol Myers Squibb
WashU and Bristol Myers Squibb have formed a multiyear collaboration to advance drug development projects in the neurosciences. WashU medical and research trainees will have opportunities to work alongside the company’s scientists at its facilities as part of the agreement.
Kouvelis featured during FreightWeekSTL 2026
WashU Olin Business supply chain expert Panos Kouvelis explains how the St. Louis region has emerged as a competitive hub for companies navigating global supply chain disruptions.
Aid for brain-bleed recovery receives FDA Breakthrough Device Designation
An earbud-like device from Aurenar, a WashU startup, is designed to improve stroke outcomes after a ruptured brain aneurysm. The technology is based on clinical trials led by WashU Medicine physician-scientists including Eric Leuthardt, MD.
Colditz, Jiang receive Chancellor’s Award for Innovation and Entrepreneurship
At the WashU Office of Technology Management’s annual
Celebration of Inventors, WashU Medicine researchers Graham Colditz and Shu (Joy) Jiang were honored for developing and commercializing a technology to predict breast cancer risk.
New minor in systems engineering for social good offered
A new minor program at WashU McKelvey Engineering will equip students with the ability to connect technical decisions with societal outcomes.
A life-saving union
Two WashU alumni prove their commitment to saving lives, to growing a business — and to one another.
How morals influence food, health decisions
Olin’s Sydney Scott researches why consumers act the way they do in the grocery aisle – and the doctor’s office.
Samsung grant will fund better energy storage systems
WashU engineering researchers led by Sang-Hoon Bae received a grant from Samsung to further their work to improve electrostatic capacitors.
WashU in top 10 universities for translating discoveries into real-world solutions
WashU was ranked ninth among U.S. universities in the inaugural Cure Innovation Index, an assessment of how effectively institutions translate research advances into market-ready innovations. The index cited WashU’s biomedical research capabilities and support for commercialization and innovation, among other strengths.
Older Stories